Poseida Therapeutics Inc (PSTX)
3.19
-0.16
(-4.63%)
USD |
NASDAQ |
May 17, 16:00
3.19
0.00 (0.00%)
After-Hours: 20:00
Poseida Therapeutics Cash from Financing (Quarterly): -0.043M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -0.043M |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 14.94M |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 1.186M |
| December 31, 2022 | 0.058M |
| September 30, 2022 | 75.84M |
| June 30, 2022 | 0.032M |
| March 31, 2022 | 29.23M |
| December 31, 2021 | 0.236M |
| September 30, 2021 | 1.855M |
| Date | Value |
|---|---|
| June 30, 2021 | 0.067M |
| March 31, 2021 | 0.36M |
| December 31, 2020 | 0.038M |
| September 30, 2020 | 206.53M |
| June 30, 2020 | 103.03M |
| March 31, 2020 | 4.346M |
| December 31, 2019 | 0.014M |
| September 30, 2019 | 7.863M |
| June 30, 2019 | 60.58M |
| March 31, 2019 | 95.92M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.043M
Minimum
Mar 2024
206.53M
Maximum
Sep 2020
25.31M
Average
0.773M
Median
Cash from Financing (Quarterly) Benchmarks
| Biomea Fusion Inc | 0.116M |
| Cartesian Therapeutics Inc | 43.03M |
| Lantern Pharma Inc | 0.0547M |
| NovaBay Pharmaceuticals Inc | -0.597M |
| Palatin Technologies Inc | 9.136M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -15.14M |
| Cash from Investing (Quarterly) | 24.00M |
| Free Cash Flow | -71.71M |
| Free Cash Flow Per Share (Quarterly) | -0.159 |
| Free Cash Flow to Equity (Quarterly) | -15.37M |
| Free Cash Flow Yield | -24.27% |